These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8519622)

  • 21. A case of peroxidase-positive acute leukaemia expressing only T lineage lymphoid markers.
    Lelong F; Chretien P; Jouault H; Bayani N; Bernaudin F; Lemerle S
    Br J Haematol; 1994 Jan; 86(1):195-7. PubMed ID: 8011530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between immunological characteristics and prognosis in children with acute myeloid leukemia].
    Gu LJ; Tie LJ; Jiang LM; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP; Ye H
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):241-5. PubMed ID: 19374802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10).
    Geller RB; Zahurak M; Hurwitz CA; Burke PJ; Karp JE; Piantadosi S; Civin CI
    Br J Haematol; 1990 Nov; 76(3):340-7. PubMed ID: 1702006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
    Thalhammer-Scherrer R; Mitterbauer G; Simonitsch I; Jaeger U; Lechner K; Schneider B; Fonatsch C; Schwarzinger I
    Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunophenotypic study of acute myeloid leukemia (AML): biological significance and prognostic implications].
    Rigolin GM; Latorraca A; Moretti S; Previati R; Lanza F
    Boll Soc Ital Biol Sper; 1993 May; 69(5):301-5. PubMed ID: 8129911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity among the acute nonlymphocytic leukemias: value of immunophenotype for diagnosis, prognosis, and therapy.
    Kamps WA; Humphrey GB
    Pediatr Hematol Oncol; 1988; 5(1):17-28. PubMed ID: 3152947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and immunophenotyping features of CD34-positive acute nonlymphoblastic leukemia].
    Chen G; Qian L; Shen D
    Zhonghua Nei Ke Za Zhi; 1995 Jan; 34(1):26-9. PubMed ID: 7541328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The use of monoclonal antibodies for immunologic typing and prognosis prediction in acute non-lymphoblastic leukemia].
    Chen GB; Tang MH; Yang TY
    Zhonghua Nei Ke Za Zhi; 1993 Jun; 32(6):405-8. PubMed ID: 7903627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD34 expression fails to predict the outcome in adult acute myeloid leukemia.
    Ciolli S; Leoni F; Caporale R; Pascarella A; Salti F; Rossi-Ferrini P
    Haematologica; 1993; 78(3):151-5. PubMed ID: 7690733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunologic classification used in typing of 68 cases of acute leukemias].
    Sun XL; Fang MY; Jiang F; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):39-41. PubMed ID: 16584588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute myeloid leukemia with concomitant expression of T-/B-lymphoid antigens and immunogenotypic alterations exhibiting t(7;12)(q32;q24).
    Kawakubo K; Ohyashiki K; Ohyashiki JH; Kuriyama Y; Iwabuchi A; Kimura N; Sugita K; Nakazawa S; Toyama K
    Leukemia; 1993 Jun; 7(6):909-11. PubMed ID: 7684801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-lymphoid/myeloid stem cell origin in Ph-positive acute leukemia with myeloid markers.
    Akashi K; Taniguchi S; Nagafuji K; Harada M; Shibuya T; Hayashi S; Gondo H; Niho Y
    Leuk Res; 1993 Jul; 17(7):549-55. PubMed ID: 8326735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of standard CD assessment in acute leukemia.
    Tupitsyn NN; Babusíková O; Baryshnikov AYu ; Ujházy P; Kadagidze ZG; Mahonova LA; Peterson IS; Protasova AK; Drozdova TS; Artemjev AK
    Neoplasma; 1990; 37(4):431-8. PubMed ID: 2146517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia.
    Gramatzki M; Ludwig WD; Burger R; Moos P; Rohwer P; Grünert C; Sendler A; Kalden JR; Andreesen R; Henschke F; Moldenhauer G
    Exp Hematol; 1998 Dec; 26(13):1209-14. PubMed ID: 9845376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophenotyping of surface antigens in acute myeloid leukemia by flow cytometry after red blood cell lysis.
    Schwonzen M; Diehl V; Dellanna M; Staib P
    Leuk Res; 2007 Jan; 31(1):113-6. PubMed ID: 16730795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0).
    Kotylo PK; Seo IS; Smith FO; Heerema NA; Fineberg NS; Miller K; Greene ME; Chou P; Orazi A
    Am J Clin Pathol; 2000 Feb; 113(2):193-200. PubMed ID: 10664621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute myeloblastic leukemia (AML-M2) expressing CD19 B-cell lymphoid antigen without myeloid surface antigens.
    Khalil SH; Jackson JM; Qari MH; Pyle H
    Leuk Res; 1994 Feb; 18(2):145. PubMed ID: 7509016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.